Sigmoidoscopy is best for bowel screens

Flexible sigmoidoscopy is the most cost-effective bowel cancer screening strategy and should be included in the national bowel cancer-screening programme, say UK researchers.

Current bowel screening pilot schemes that target individuals aged 58–69 years use faecal occult blood testing in conjunction with further investigation by colonoscopy.  

Researchers produced a colorectal cancer-screening model to inform the DoH’s policy on bowel cancer screening.  

They looked at the costs, effects and resource impact of five different screening options.  

They found screening using flexible sigmoidoscopy, with or without faecal occult blood testing, might be more cost-effective  and produce benefits compared with a policy of no screening.  

However, the researchers warn that the introduction of any screening option would require significant investment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

Enhanced service contract for GP practices delivering COVID-19 vaccine revealed

GP practices have until midnight on 7 December to sign up to a COVID-19 enhanced...